C O Esquivel
Affiliation: Stanford University
- Liver transplantation: where we are and where we are headingC O Esquivel
Stanford University School of Medicine, Palo Alto, California, USA
Transplant Proc 42:610-2. 2010....
- Resection versus transplantation for hepatocellular carcinomaC O Esquivel
Department of Surgery, Stanford University School of Medicine, California, USA
J Gastroenterol Hepatol 14:S37-41. 1999..This review will address the results observed following resection or transplantation for hepatocellular carcinoma...
- Does Asian race affect hepatitis B virus recurrence or survival following liver transplantation for hepatitis B cirrhosis?S K So
Department of Surgery and Medicine, Stanford Asia Liver Center, Stanford University School of Medicine, California, USA
J Gastroenterol Hepatol 14:S48-52. 1999..The incidence of post-transplant HBV recurrence was similar: 0% in Asians compared with 7% in non-Asians. There was no recurrence in the group of 12 patients who were HBV-DNA or HBeAg negative pretransplant...
- Human hepatocytes produce an isoform of FAS that inhibits apoptosisS M Krams
Department of Surgery, Stanford University School of Medicine, California 94305, USA
Transplantation 65:713-21. 1998..The purpose of this study was to determine if soluble variants of Fas are produced in the liver and to determine if blockade of the Fas pathway, by liver-derived soluble Fas, inhibits Fas-mediated apoptosis...
- PI3Kδ inhibition augments the efficacy of rapamycin in suppressing proliferation of Epstein-Barr virus (EBV)+ B cell lymphomasS Furukawa
Division of Abdominal Transplantation, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA
Am J Transplant 13:2035-43. 2013....
- Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimusS Cao
Department of Surgery, Loma Linda University Medical Center, California 92354, USA
Pediatr Transplant 3:22-6. 1999..However, the trade-off is a potential increased incidence of EBV-related PTLD in these patients...
- Liver transplantation in the first three months of lifeE S Woodle
Department of Surgery, University of Chicago, Illinois 60637, USA
Transplantation 66:606-9. 1998..Although infants in the first 3 months of life have not traditionally been considered a distinct age group, several features of these infants may distinguish them from other pediatric liver transplant recipients...
- Apoptosis and allograft rejection in the absence of CD8+ T cellsY Ogura
Transplant Immunobiology Laboratory, Department of Surgery, Stanford University School of Medicine, 1201 Welch Road, Stanford, CA 94305-5492, USA
Transplantation 71:1827-34. 2001..CONCLUSION: These data indicate that in the absence of CD8+ T cells an alternative pathway, associated with granzyme B and FasL expression and activation of the caspase cascade, can mediate apoptosis and graft rejection...
- Syk-induced phosphatidylinositol-3-kinase activation in Epstein-Barr virus posttransplant lymphoproliferative disorderO Hatton
Program in Immunology, Department of Surgery Division of Abdominal Transplantation, Stanford University School of Medicine, Stanford, CA, USA
Am J Transplant 13:883-90. 2013..Taken together, our data indicate that Syk activates PI3K/Akt signaling which is required for survival of EBV+ B cell lymphomas. PI3K/Akt signaling may be a promising therapeutic target for PTLD, and other EBV-associated malignancies...
- Acute rejection of small intestine allografts is associated with increased expression of toll-like receptorsR O Castillo
Lucile Packard Children s Hospital, Stanford University School of Medicine, Palo Alto, USA
Transplant Proc 42:2676-8. 2010..These preliminary studies suggest an important role for in innate immune system in acute rejection of the small intestinal allografts, and as such represents an emerging and promising area of investigation...
- Epstein-Barr virus modulates host cell microRNA-194 to promote IL-10 production and B lymphoma cell survivalA Harris-Arnold
Department of Surgery, Division of Abdominal Transplantation, Stanford University School of Medicine, Stanford, CA
Am J Transplant 15:2814-24. 2015..Thus, modulation of microRNA-194 may constitute a novel approach to inhibiting proliferation of EBV(+) B cell lymphomas in PTLD. ..
- Major hepatic resection without blood transfusion: experience with total vascular exclusionS K So
Department of Surgery, Stanford University School of Medicine, Stanford Asian Liver Center, California, USA
J Gastroenterol Hepatol 14:S28-31. 1999..It further obviates the need for dissection of the porta hepatis and its associated risks. Total vascular exclusion time of 30 min appears to be well tolerated, even in patients with compensated cirrhosis...
- Epstein-Barr virus infection is associated with endothelial Bcl-2 expression in transplant liver allograftsM T Millan
Department of Surgery, Division of Multi Organ Transplantation, Stanford University School of Medicine, Palo Alto, CA 94304, USA
Transplantation 73:465-9. 2002..Bcl-2, an antiapoptotic factor induced by EBV in various host cells, is not normally expressed in the liver. We questioned whether bcl-2 is expressed in the transplanted liver and whether its expression is modified by EBV...
- Pediatric intestinal transplantation at Packard Children's Hospital/Stanford University Medical Center: report of a four-year experienceR O Castillo
Division of Gastroenterology, Nutrition and Liver Disease, Department of Pediatrics, Packard Children s Hospital, Palo Alto, CA 94304, USA
Transplant Proc 38:1716-7. 2006..Outcomes achieved levels expected based on The Intestinal Transplant Registry and UNOS criteria, which were better than expected for isolated intestinal transplants and achievement of enteral autonomy...
- Resistance to Fas-mediated apoptosis in EBV-infected B cell lymphomas is due to defects in the proximal Fas signaling pathwayA L Snow
Program in Immunology and Department of Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA
J Immunol 167:5404-11. 2001....